Alphapharm Pty. Ltd.
http://www.alphapharm.com.au
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Alphapharm Pty. Ltd.
MSD’s Ontruzant Gets Australian Reimbursement
Merck Sharp & Dohme’s Ontruzant has become the fourth trastuzumab biosimilar to be reimbursed in Australia, while Pfizer’s Trazimera is in line to be the fifth.
Australian Advisors Will Ponder Sandoz’ Pegfilgrastim And Pfizer’s Trastuzumab
A body that advises Australia’s Department of Health on reimbursement will in November consider listing applications for Sandoz’ Ziextenzo pegfilgrastim candidate and well as for Pfizer’s recently authorized Trazimera trastuzumab brand.
Orange Book Policing May Increase, US FDA's Gottlieb Says
Commissioner says agency will modernize drug patent reference manual this year and consider potential changes to Orange Book administration policy. However, any transformative moves could trigger a court challenge.
Australian Pharmaceutical Industry Says Export, Sales Figures Mask Trouble On The Horizon
Australia’s pharmaceutical industry says it faces hard times, despite a recent report highlighting sales and exports. But challenges are expanding for many companies that face patent expirations, paving the way for generic manufacturers to drive prices down.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice